Connect with us

Hi, what are you looking for?

Saturday, Apr 19, 2025

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "U.S FDA"

Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease

Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease

Medical and Pharmaceutical

Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease

This approval is a hard-won victory for Soleno after a lengthy clinical trial phase

Joseph MortonMarch 27, 2025

Lipella Pharmaceuticals skyrockets on FDA access approval for nasty mouth disease treatment

Lipella Pharmaceuticals skyrockets on FDA access approval for nasty mouth disease treatment

Medical and Pharmaceutical

Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment

The stock was up by about 200% during early trading hours

Rowan DunneFebruary 6, 2025

Filament Health gets FDA approval for psilocybin studies on cancer-related anxiety and depression

Filament Health gets FDA approval for psilocybin studies on cancer-related anxiety and depression

Psychedelics

Filament Health gets FDA approval for psilocybin studies on cancer-related anxiety and depression

The clinical trials will examine the effects of the company's botanical psilocybin drug candidate PEX010

Rowan DunneAugust 10, 2023

U.S. FDA publishes first draft guidance document for clinical trials involving psychedelics

U.S. FDA publishes first draft guidance document for clinical trials involving psychedelics

Psychedelics

FDA publishes first draft guidance document for psychedelics research

It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics

Rowan DunneJune 23, 2023

More Posts